REGENERON PHARMACEUTICALS, INC.
Pharmaceutical Preparations | SIC: 2834Phone: 9148477000
EIN: 133444607
State Location: NY
State of Inc.: NY
- Nasdaq:REGN
Form: 8-K
Filing Date: 29 Apr 2026Report Date: 29 Apr 2026
Accepted: 29 Apr 2026 04:50 a.m.
Accession Number: 0000872589-26-000014
File Number: 000-19034
Film Number: 26910416
Items: 2.02,9.01
Documents
Primary Document: 8-K
Accepted: 29 Apr 2026 04:50 a.m.
0000872589-26-000014-index-headers.html
Last Modified: 29 Apr 2026 04:50 a.m.
0000872589-26-000014-index.html
Last Modified: 29 Apr 2026 04:50 a.m.
0000872589-26-000014.txt
Last Modified: 29 Apr 2026 04:50 a.m.
0000872589-26-000014-xbrl.zip
Last Modified: 29 Apr 2026 04:50 a.m.
exhibit991q12026.htm
Last Modified: 29 Apr 2026 04:50 a.m.
FilingSummary.xml
Last Modified: 29 Apr 2026 04:50 a.m.
image0a12a.jpg
Last Modified: 29 Apr 2026 04:50 a.m.
MetaLinks.json
Last Modified: 29 Apr 2026 04:50 a.m.
R1.htm
Last Modified: 29 Apr 2026 04:50 a.m.
regn-20260429.xsd
Last Modified: 29 Apr 2026 04:50 a.m.
regn-20260429_htm.xml
Last Modified: 29 Apr 2026 04:50 a.m.
regn-20260429_lab.xml
Last Modified: 29 Apr 2026 04:50 a.m.
regn-20260429_pre.xml
Last Modified: 29 Apr 2026 04:50 a.m.
report.css
Last Modified: 29 Apr 2026 04:50 a.m.
Show.js
Last Modified: 29 Apr 2026 04:50 a.m.